2014年11月5日星期三

Is Kidney Transplant Useful for IgA Nephropathy

Is kidney transplant useful for IGA Nephropathy? This article will explain it in details.

IgA nephropathy is a kind of kidney disease pertains to glomerulonephritis, which can easily lead to ESRD, then patients have to receive kidney transplantation.
However, it is common to see that the IgA nephropathy recurrence in the patient after kidney transplantation. IgA nephropathy is not a kidney problem, but a immune system problem, to put it simply, it is a disease resulting from gene. So that even after kidney transplant, IgA nephropathy may come back again.

According to the statistics, after kidney transplantation, the recurrence rate of IgA nephropathy is 13%~50%, clinical manifestations is the same as original symptoms, includes hematuresis, proteinuria and progressive renal function decline. In the beginning phase, the course of disease is benign, but long-term follow-up data show that there are 1.3%~16% of patients’ donor kidney have lost efficacy due to IgA nephropathy recurrence. Recently, a large-sample study shows that in ten years after kidney transplantation, the rate of donor kidney lost efficacy due to IgA nephropathy is about 9.7%.

At present, there is no effective prevention and treatment measures for the recurrence of IgA nephropathy. Some people pin their hope on currently available immunosuppressive drugs, but there were no signs of the drugs can prevent IgA nephropathy recurrence.

Thus it can be seen that kidney transplantation is not a foolproof method to treat IgA nephropathy, in this case, what should patients do to deal with IgA nephropathy?


Micro-Chinese Medicine Osmotherapy is a put forward by many renal experts in Shijiazhuang Kidney Disease Hospital. It is external application, this therapy can help patients to expend blood vessels and improve the blood circulation, so as to eliminate the immune complexes more completely. With this application, more and more kidney function will be improved. and avoid kidney transplant.

没有评论:

发表评论